MDS Virtual Congress 2021

September 17-22, 2021. Virtual Congress. www.mdscongress.org

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Patient-Reported Impact of Standard-of-Care: Change in Symptoms Following Dopamine Initiation and Deep Brain Stimulation

L. Mischley, C. Weaver, J. Farahnik, Y. Chien (Kenmore, USA)
Patterns and determinants of healthcare utilization among people with Parkinson’s disease: A population based analysis in Ontario, Canada

E. Crighton, A. Ouédraogo, M. Sawada, T. Mestre (Ottawa, Canada)
Patterns of Cortical Thinning in Patients with Parkinson’s Disease

H. Jergas, JC. Baldermann, JN. Petry-Schmelzer, H. Dafsari, V. Visser-Vanderwalle, T. Dembek, M. Barbe (Cologne, Germany)
Patterns of Improvement with Valbenazine in Patients with Tardive Dyskinesia

C. Correll, T. Carmack, C. Shah, L. Lundt (Glen Oaks, USA)
PD phenotype with premotor RBD is associated with a dysbiotic profile of gut microbiota.

V. Oppo, S. Vascellari, M. Melis, A. Manzin, G. Cossu (Cagliari, Italy)
People living with Parkinson’s disease during the COVID-19 Pandemic: A cross-sectional survey of the Canadian experience

M. Mckeown, T. Mestre, E. Crighton (Ottawa, Canada)
Perampanel as a treatment for Orthostatic Tremor

E. Vander Woude (Amsterdam, Netherlands)
Perampanel inhibits α-synuclein transmission in Parkinson’s disease models

J. Ueda, N. Uemura, R. Takahashi (Kyoto, Japan)
PERCEPTION OF INDIVIDUALS WITH PARKINSON´S DISEASE ABOUT ISOLATION DURING THE COVID-19 PANDEMIC

R. Pasquarelli Volpe, L. Laskovski, S. Mahmoud Smaili (Londrina, Brazil)
Peripheral immune profile and neutrophil-to-lymphocyte ratio in Parkinson’s disease

L. Muñoz-Delgado, D. Macías-García, S. Jesús, JF. Martin-Rodríguez, MA. Labrador-Espinosa, MV. Jiménez-Jaraba, A. Adarmes-Gómez, F. Carrillo, P. Mir (Sevilla, Spain)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z